| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Total other income (expense), net | 19,315 | 28,757 | ||
| Net loss | -1,597,632 | -1,956,604 | ||
| Net loss applicable to common stockholders | -1,597,632 | - | ||
| Net loss per share to common stockholders basic (in dollars per share) | -1.01 | -1.41 | ||
| Net loss per share to common stockholders diluted (in dollars per share) | -1.01 | -1.41 | ||
| Weighted average common shares outstanding basic (in shares) | 1,574,535 | 1,387,118 | ||
| Weighted average common shares outstanding diluted (in shares) | 1,574,535 | 1,387,118 | ||
Bluejay Diagnostics, Inc. (BJDX)
Bluejay Diagnostics, Inc. (BJDX)